2025 Rachmiel Levine-Arthur Riggs Diabetes Research Symposium
- Institution
- BECKMAN RESEARCH INSTITUTE/CITY OF HOPE, CA
- Principal investigator
- Fouad R Kandeel
- Funding
- $20K
- Duration
- 2025–2026
Moonbase score
Still being scored
Abstract
PROJECT SUMMARY 2025 Rachmiel Levine-Arthur Riggs Diabetes Research Symposium November 14-17, 2025, Westin Pasadena, Pasadena, CA Despite the significant knowledge obtained and the progress made in the treatment of diabetes over the last 50 years since the discovery of insulin, translation of this understanding to the clinic, and implementation of acceptable standards of care for diabetics has been suboptimal. In view of the rapidly growing worldwide diabetes epidemic - the disease affected 22.3 million people in the USA and 371 million people worldwide in 2012, and is expected to double by 2030 if current trends hold - it is imperative to enhance current interactions among investigators. This is to foster new collaborations, and pool knowledge and resources so that the cellular and molecular mechanisms responsible for the disease and its complications can be determined, and novel therapeutic strategies developed that will effectively prevent, delay, and even cure diabetes. The 2025 Rachmiel Levine-Arthur Riggs Diabetes Research Symposium, to be held from November 14-17, 2025 at The Westin in Pasadena, California, will continue to meet the growing demand to keep researchers, clinicians and trainees abreast of the latest developments in diabetes- and endocrine-related research. The Symposium is organized by the City of Hope’s Arthur Riggs Diabetes and Metabolism Research Institute (AR-DMRI) and is expected to attract over 250 attendees from both the U.S. and abroad with diverse academic backgrounds including, endocrinologists, diabetologists, islet biologists, stem cell and gene transfer scientists, transplant scientists, immunologists, cell biologists, young investigators in all these areas, and health care professionals who manage individuals with diabetes. The four-day meeting will offer presentations from over 60 experts in the field of type 1 diabetes and islet cell biology. The meeting will consist of introductory lectures and plenary sessions that will each conclude with a panel discussion. In addition, the meeting will offer a debate session, oral presentations from junior investigators and trainees, and a poster session for both junior and established investigators to present new and exciting data. The Symposium provides an important venue for investigators to present their data to an audience of national and international experts, helping to foster the career growth of junior investigators.
LOADING MOONBASE SCORE
Questions for BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
Answered by the team behind this research.
No questions yet. Sign in to ask the first one
Related grants
Same institution, same topic, scored first.
- NIH · Beckman Research Institute/City of Hope47
Repurposing Leflunomide to Delay Progression of Smoldering Multiple Myeloma in African Americans
Flavia Pichiorri · $678K · 2021–2027
- NIH · Beckman Research Institute/City of Hope43
TET2-mediated epitranscriptomic regulation in leukemia microenvironment
Jianjun Chen · $685K · 2023–2028
- NIH · Beckman Research Institute/City of Hope41
Elucidating the Cellular Origins of lung adenocarcinoma
Crystal Nicole Marconett · $433K · 2023–2029